Search Results - "Biltaji, Eman"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection by Varier, Raghu U, Biltaji, Eman, Smith, Kenneth J, Roberts, Mark S, Kyle Jensen, M, LaFleur, Joanne, Nelson, Richard E

    “…Clostridium difficile infection (CDI) places a high burden on the US healthcare system. Recurrent CDI (RCDI) occurs frequently. Recently proposed guidelines…”
    Get full text
    Journal Article
  5. 5

    Impact of genomic profiling on treatment decisions for patients with melanoma and colorectal cancer cohorts by Biltaji, Eman, Au, Trang H., Gligorich, Keith, Bronner, Mary P., Stenehjem, David D., Brixner, Diana I.

    Published in Journal of clinical oncology (10-03-2017)
    “…Abstract only 66 Background: Clinical guidelines recommend RAS testing and BRAF testing in CRC and melanoma, respectively, to guide treatment (tx) decisions…”
    Get full text
    Journal Article
  6. 6

    Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome by Tak, Casey R., Biltaji, Eman, Kohlmann, Wendy, Maese, Luke, Hainaut, Pierre, Villani, Anita, Malkin, David, Sherwin, Catherine M.T., Brixner, Diana I, Schiffman, Joshua D.

    Published in Pediatric blood & cancer (01-05-2019)
    “…Introduction Patients with germline TP53 pathogenic variants (Li–Fraumeni syndrome [LFS]) are at extremely high lifetime risk of developing cancer. Recent data…”
    Get full text
    Journal Article
  7. 7

    Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? by Biltaji, Eman, Walker, Brandon, Au, Trang H, Rivers, Zachary, Ose, Jennifer, Li, Christopher I, Brixner, Diana I, Stenehjem, David D, Ulrich, Cornelia M

    “…Inherited genetic variants can modify the cancer-chemopreventive effect of aspirin. We evaluated the clinical and economic value of genotype-guided aspirin use…”
    Get full text
    Journal Article
  8. 8

    Cost-effectiveness of genotype-guided aspirin use for colorectal cancer prevention by Biltaji, Eman, Au, Trang H., Walker, Brandon, Ose, Jennifer, Ulrich, Cornelia M, Stenehjem, David D., Brixner, Diana I.

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e18318 Background: Colonoscopy is the “gold standard” for colorectal cancer (CRC) screening. However, adherence rates are low and detection is…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Supportive care medications coinciding with chemotherapy among children with hematologic malignancy by Biltaji, Eman, Enioutina, Elena Y., Yellepeddi, Venkata, Rower, Joseph E., Sherwin, Catherine M. T., Ward, Robert M., Lemons, Richard S., Constance, Jonathan E.

    Published in Leukemia & lymphoma (02-07-2020)
    “…Pharmacokinetic (PK) conflicts can arise between supportive care medications (SCM) and chemotherapy in children with hematologic malignancy (HM). In this…”
    Get full text
    Journal Article
  11. 11

    Clinical utility of multigene versus single gene genomic profiling in metastatic colorectal cancer by Biltaji, Eman

    Published 01-01-2016
    “…Routine KRAS mutations testing in metastatic colorectal cancer (CRC) patients to guide anti-EGFR-targeted therapy use is recommended by clinical guidelines…”
    Get full text
    Dissertation
  12. 12

    Using Electronic Medical Records to Assess the Effectiveness of Pharmacotherapy in Pain: A Review of Recent Observational Studies by Biltaji, Eman, Tak, Casey, Ma, Junjie, Ruiz-Negron, Natalia, Bellows, Brandon K.

    “…Pain disorders affect a large number of individuals throughout the world and are costly. Although randomized clinical trials assess the efficacy (i.e., how…”
    Get full text
    Journal Article
  13. 13

    Real-World Evidence in Pain Research: A Review of Data Sources by Bellows, Brandon K., Kuo, Kuan-Ling, Biltaji, Eman, Singhal, Mukul, Jiao, Tianze, Cheng, Yan, McAdam-Marx, Carrie

    “…ABSTRACT Outcomes research studies use clinical and administrative data generated in the course of patient care or from patient surveys to examine the…”
    Get full text
    Journal Article
  14. 14

    Outcomes associated with pharmacist‐led diabetes collaborative drug therapy management in a medicaid population by Biltaji, Eman, Yoo, Minkyoung, Jennings, Brandon T., Leiser, Jennifer P., McAdam‐Marx, Carrie

    “…Objectives Pharmacist‐led diabetes collaborative drug therapy management (CDTM) has been shown to improve outcomes. Whether such programmes are effective…”
    Get full text
    Journal Article
  15. 15

    Students’ perceptions of pharmacy as a specialization and their future career : a cross sectional study of final year pharmacy students in Jordan by al-Ifan, Qays, Biltaji, Iman, Nusayr, Khawlah Qasim, Jarab, Anan Sadiq, Mukattash, Tariq Luwis

    Published in Jordan journal of pharmaceutical sciences (01-09-2015)
    “…تهدف هذه الدراسة إلى خلق فهم للأسباب التي تدفع الطلاب لدراسة تخصص الصيدلة و استكشاف مخططاتهم المستقبلية بما يخص خياراتهم الوظيفية. قام الباحثون بتوزيع استبانه…”
    Get full text
    Journal Article